Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Completed · Phase 3

Conditions studied: Dry Eye Syndromes

In brief

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

Key facts

Study ID

NCT00502073

Run by

Sirion Therapeutics, Inc.

Last updated by the study team

2011-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease

You may not qualify if…

• Intraocular or refractive surgery in the study eye within 3 months prior to study start
• Unwilling to discontinue use of contact lenses during the run-in and duration of the study
• Pregnancy or lactation

Where it is running

• Eye Center Northeast — Bangor, Maine, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.